The FDA Approves New Treatment for Chronic Lymphocytic Leukemia Under an International Program
According to a story from PR Newswire, the US Food and Drug Administration (FDA) has recently granted supplemental approval to the drug acalabrutinib (marketed as Calquence) as a treatment for…